The tumour suppressor gene CEACAM1 is completely but reversibly downregulated in renal cell carcinoma
- 8 October 2004
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 204 (3) , 258-267
Abstract
CEACAM1 acts as a tumour suppressor in various epithelial tumours. On the other hand, de novo expression of CEACAM1 is strongly associated with reduced disease‐free survival of melanoma and non‐small cell lung carcinoma patients. Since effector functions of natural killer and T cells are inhibited by homophilic CEACAM1 interaction, immune escape could be responsible for the poor prognosis of these patients. Here, we describe CEACAM1 expression in normal kidney, renal adenomas and renal cell carcinomas (RCC) using a novel antibody generated by genetic immunization. In normal kidney, CEACAM1 was found in epithelial cells of proximal tubules and in endothelial cells. In contrast, tumour cells of 30 clear cell, three chromophobic, and two chromophilic RCCs were completely devoid of CEACAM1. Renal adenomas also lacked CEACAM1 expression. Similarly, RCC cell lines CaKi1, CaKi2, A498, and RCC26 exhibited no or low‐level CEACAM1 expression. However, CEACAM1 expression was transiently induced in A498 cells upon contact with allogeneic CD8+ T cells, mediated at least in part by interferon‐γ. Furthermore, the majority of tumour‐infiltrating T and NK cells expressed CEACAM1 upon stimulation. Thus, transient expression of the tumour suppressor CEACAM1 by tumour cells and subsequent homophilic interaction with CEACAM1 on tumour‐infiltrating lymphocytes could represent a novel immune escape mechanism in RCC. Copyright © 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 35 references indexed in Scilit:
- Specific Regulation of T Helper Cell 1–mediated Murine Colitis by CEACAM1Journal of Experimental Medicine, 2004
- Interferon‐γ Tempers the Expression of Carcinoembryonic Antigen Family Molecules in Human Colon Cells: a Possible Role in Innate Mucosal DefenceScandinavian Journal of Immunology, 2003
- Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytesNature Immunology, 2002
- CEA-Related Cell Adhesion Molecule 1Molecular Cell, 2000
- Tumor-suppressive activity of CD66a in prostate cancerCancer Gene Therapy, 1999
- The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissuesSeminars in Cancer Biology, 1999
- Biliary glycoprotein (CD66a), a cell adhesion molecule of the immunoglobulin superfamily, on human lymphocytes: structure, expression and involvement in T cell activationEuropean Journal of Immunology, 1998
- Association of biliary glycoprotein with protein tyrosine phosphatase SHP-1 in malignant colon epithelial cellsOncogene, 1997
- Role of Interferon Regulatory Factor-1 in the Induction of Biliary Glycoprotein (Cell CAM-1) by Interferon-γJournal of Biological Chemistry, 1996
- Cea expression of colorectal adenocarcinomas is correlated with their resistance against lak‐cell lysisInternational Journal of Cancer, 1994